Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
Stepkowski
S M
SM
Division of Immunology and Organ Transplantation, University of Texas Medical School 77030.
Kahan
B D
BD
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D004357:Drug Synergism; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D011090:Polyenes / Q000627:therapeutic use*; D051381:Rats; D011915:Rats, Inbred BUF; D011920:Rats, Inbred WF; D020123:Sirolimus; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D020123:Sirolimus